We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $72.6B
1-Year Est. Return 54.88%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+6.64%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$56.6B
AUM Growth
+$4.03B
Cap. Flow
+$1.92B
Cap. Flow %
3.4%
Top 10 Hldgs %
7.89%
Holding
3,713
New
413
Increased
1,833
Reduced
1,026
Closed
416
Avg Time Held
6.5 quarters
Top 10 Avg Time Held
5.3 quarters
Top 20 Avg Time Held
4.5 quarters

Sector Composition

Rank Sector Weight
1 Technology 16.75%
2 Healthcare 13.12%
3 Financials 12.46%
4 Consumer Staples 9.7%
5 Industrials 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MMAC
2926
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$340K ﹤0.01%
+18,667
New +$342K
2016 Q3
0 quarters
MDR
2927
DELISTED
McDermott International
MDR
$339K ﹤0.01%
22,533
+3,566
+19% +$53.3K
2016 Q2
1 quarter
PHIO icon
2928
Phio Pharmaceuticals
PHIO
$11.4M
$336K ﹤0.01%
3
+1
+50% +$135K
2015 Q1
6 quarters
NVTR
2929
DELISTED
Nuvectra Corporation Common Stock
NVTR
$336K ﹤0.01%
48,500
-5,100
-10% -$35K
2016 Q2
1 quarter
BAP icon
2930
Credicorp
BAP
$30.3B
$335K ﹤0.01%
+2,200
New +$347K
2016 Q3
0 quarters
BPMC
2931
DELISTED
Blueprint Medicines
BPMC
$333K ﹤0.01%
+11,200
New +$278K
2016 Q3
0 quarters
ELDN icon
2932
Eledon Pharmaceuticals
ELDN
$202M
$330K ﹤0.01%
1,333
+1,248
+1,468% +$457K
2015 Q4
3 quarters
SYUT
2933
DELISTED
Synutra International, Inc.
SYUT
$330K ﹤0.01%
77,400
-5,700
-7% -$21.5K
2013 Q2
13 quarters
GMAN
2934
DELISTED
Gordmans Stores, Inc.
GMAN
$329K ﹤0.01%
375,600
+154,400
+70% +$176K
2013 Q2
13 quarters
ICBK
2935
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$324K ﹤0.01%
+16,200
New +$334K
2016 Q3
0 quarters
IRS
2936
IRSA Inversiones y Representaciones
IRS
$1.16B
$323K ﹤0.01%
+17,650
New +$309K
2016 Q3
0 quarters
BVH
2937
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$322K ﹤0.01%
+3,120
New +$291K
2016 Q3
0 quarters
HSBC icon
2938
HSBC
HSBC
$318B
$320K ﹤0.01%
9,409
-1,389,921
-99% -$43.6M
2016 Q1
2 quarters
VATE icon
2939
INNOVATE Corp
VATE
$98.5M
$320K ﹤0.01%
+5,862
New +$270K
2016 Q3
0 quarters
WVVI icon
2940
Willamette Valley Vineyards
WVVI
$10.5M
$320K ﹤0.01%
40,000
+7,000
+21% +$56.9K
2013 Q3
12 quarters
IVTY
2941
DELISTED
Invuity, Inc
IVTY
$317K ﹤0.01%
+23,100
New +$274K
2016 Q3
0 quarters
GEN
2942
DELISTED
Genesis Healthcare, Inc.
GEN
$313K ﹤0.01%
117,400
+105,000
+847% +$241K
2015 Q1
6 quarters
BNED icon
2943
Barnes & Noble Education
BNED
$434M
$312K ﹤0.01%
326
-201
-38% -$222K
2016 Q2
1 quarter
LGL icon
2944
LGL Group
LGL
$86.1M
$312K ﹤0.01%
193,596
+1,061
+0.6% +$1.51K
2013 Q2
13 quarters
MTBL
2945
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$312K ﹤0.01%
+101,067
New +$275K
2016 Q3
0 quarters
ESEA icon
2946
Euroseas
ESEA
$503M
$311K ﹤0.01%
23,792
+4,440
+23% +$57.8K
2013 Q2
13 quarters
VIVS
2947
VivoSim Labs
VIVS
$2.41M
$311K ﹤0.01%
+342
New +$335K
2016 Q3
0 quarters
AEY
2948
DELISTED
ADDvantage Technologies Group
AEY
$311K ﹤0.01%
17,790
+820
+5% +$15.2K
2013 Q2
13 quarters
INDT
2949
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$311K ﹤0.01%
9,800
+600
+7% +$18.9K
2016 Q2
1 quarter
OSG
2950
DELISTED
Overseas Shipholding Group Inc.
OSG
$310K ﹤0.01%
29,300
+12,001
+69% +$137K
2016 Q2
1 quarter

Similar funds

Renaissance Technologies's Q3 2016 Portfolio in Review

As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.

  • Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
  • Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
  • Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
  • Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
  • Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
  • Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
  • Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.

Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.